Patrik Jonsson, EVP of Eli Lilly and president of Lilly International, said in an April 30 earnings call that while the company only has a few weeks worth of data from India on how generic semaglutide is impacting the market, it seems the generics are really stimulating the growth in the overall obesity market, and that includes [Mounjaro]. Prescriptions for Mounjaro have been 10% higher in recent weeks compared to before generic semaglutide was introduced, he added
Zepbound (tirzepatide) is a GLP-1 and GIP receptor agonist approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbid condition
Severe abdominal pain, particularly if it radiates to the back, could indicate pancreatitis, a rare but serious adverse event associated with GLP-1 therapy
It is important to note that most insurance plans do not cover semaglutide for weight loss and often require patients to meet criteria in order to earn the semaglutide discount
Poletti S, Mazza MG, Benedetti F